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Background Exogenous adenosine has been shown to increase muscle sympathetic nerve activity (MSNA), blood pressure, heart rate, and ventilation in conscious humans, effects attributed to peripheral chemoreceptor activation.
Methods and Results To determine whether endogenous adenosine has similar effects and whether they are mediated through chemoreceptor activation, we examined the effects of dipyridamole, an inhibitor of adenosine reuptake, on sympathetic nerve activity and ventilation. Twenty studies were conducted on separate days in 15 healthy volunteers. We examined responses to dipyridamole 0.56 mg/kg during room air breathing (n=7), during hyperoxia (100% 02, n=6), and during room air breathing after pretreatment with aminophylline (n=7). During room air breathing, dipyridamole increased MSNA from 231±42 to 504±136 U/min, heart rate from 65±3.8 to 96±4.7 beats per minute, and systolic blood pressure from 129±3.5 to 140±4.8 mm Hg; central venous pressure decreased from 5.5 ±0.4 to 4.5±0.3 mm Hg (P<.01), and minute ventilation increased from 7.8±0.6 to 9.1±0.5 l/min (P<.01).
During peripheral chemoreceptor suppression (with hyperoxia), there was a dissociation of the effects of dipyridamole on ventilation and sympathoexcitation. Effects on ventilation were attenuated, but sympathoexcitatory effects were not. Pretreatment with aminophylline, an adenosine receptor antagonist, either abolished (blood pressure, minute ventilation, and endtidal CO2) or markedly attenuated (MSNA and heart rate) the effects of dipyridamole during room air breathing.
Conclsions Augmentation of endogenous adenosine with dipyridamole increases sympathetic nerve activity and ventilation in conscious humans. The ventilatory effects of endogenous adenosine are mediated predominantly by chemoreceptor activation, but the sympathetic and hemodynamic responses to endogenous adenosine are probably mediated by an additional afferent mechanism that is independent of peripheral chemoreceptor activation. (Circulation. 1994;90:2919-2926.)
Key Words * dipyridamole * microneurography autonomic nervous system * chemoreceptors * adenosine A denosine, an endogenous nucleoside, has potent cardiac electrophysiological effects.1-3 In supraventricular tissue, its electrophysiological actions are mediated primarily through its effects on potassium conductance, whereas its actions on ventricular myocardium are mediated through an antiadrenergic effect.1 Adenosine is also a vasodilator in most vascular beds and produces sustained hypotension in anesthetized subjects,4-9 mainly by decreasing peripheral vascular resistance.8 '9 The relative lack of reflex sympathetic activation in response to adenosine-induced hypotension in anesthetized subjects8"10" has been attributed to the inhibitory role of adenosine as a neuromodulator,12"13 that is, inhibition of neurotransmission in sympathetic ganglia"l"l4"15 and inhibition of norepinephrine release from efferent sympathetic nerves.14 In contrast to its effects in anesthetized patients, exogenous adenosine results in sympathetic neural activation rather than inhibition in conscious subjects.16"17 Adenosine increases systolic blood pressure, heart rate, and ventilation, effects shown to correlate with an Although the effects of exogenous adenosine on sympathetic activity are well defined, the effect of endogenous adenosine on sympathetic nerve activity and its potential mediation through chemoreceptor activation has not been examined. To determine whether endogenous adenosine has sympathoexcitatory effects and, if so, whether they are mediated through chemoreceptor activation, we examined the effects of dipyridamole on sympathetic nerve activity and ventilation. In addition to its inhibitory effects on phosphodiesterase, dipyridamole inhibits the cellular reuptake and metabolism of adenosine,2324 thereby increasing its extracellular concentration and activity at the adenosine receptor.
Methods Subjects protocols on separate days. All subjects were healthy, none took medication, and all had abstained from caffeine-containing beverages for at least 24 hours before the study. The continuously recorded with a paper chart recorder, and all parameters were acquired for further analysis with a computer using customized LABVIEW software (LabView 2 Software System, National Instruments).
Experimental Protocols
After placement of all catheters and microelectrodes for nerve recordings, the subjects rested for 10 to 15 minutes. All experiments were performed with the subjects in supine position. Three protocols were performed.
Effects of Dipyridamole During Room Air Breathing and Hyperoxia
To determine the cardiovascular and respiratory effects of dipyridamole and to assess the role of peripheral chemoreceptors in mediating these actions, we compared the effects of dipyridamole during room air breathing (protocol 1) with those during hyperoxia (suppression of peripheral chemoreceptor activity,31 protocol 2) (Fig 1) . Five minutes of baseline data were first recorded, and values for MSNA, systolic, diastolic, and central venous pressures, heart rate, minute ventilation, respiratory rate, end-tidal C02, and oxygen saturation were averaged over this period. Subjects were then switched (blindly) to breathe either room air (n=7) or 100% 02 (n=6) for the remaining part of the protocol. Data were again recorded and averaged for a 3-minute period before dipyridamole 0.56 mg/kg was infused over 4 minutes. After an equilibration period of 5 minutes, data were collected for 3 minutes. Comparisons were made between "control" and "dipyridamole" in the group breathing room air throughout the experiment and between "control," "hyperoxia," and "dipyridamole+hyperoxia" in the subjects switched to breathing 100% 02.
Effects of Aminophylline on the Actions of Dipyridamole
To determine whether aminophylline, an adenosine receptor antagonist, prevents the sympathoexcitatory and respiratory effects of dipyridamole, we performed the following protocol (protocol 3, Fig 1) . After baseline measurements, aminophylline 5.6 mg/kg was infused over 20 minutes, which was followed by a maintenance infusion of 0.04 mg/kg per minute. Ten minutes into the maintenance infusion, blood samples were drawn for determination of aminophylline levels, and a second period of data collection (over 3 minutes) was obtained to assess the effects of aminophylline alone on MSNA, heart rate, blood pressure, and respiratory function during room air breathing. Dipyridamole was then administered in the same manner as described above and after 5 minutes of equilibration, data were collected for another 3-minute period. Aminophylline levels were determined with a commercially available immunoassay (Abbott Laboratories).
Data Analysis
Sympathetic bursts in nerve recordings were identified by their characteristic morphology and relation to ECG R waves. Burst amplitude was analyzed with a digitizing tablet (Sigma Scan, Jandel Scientific), and burst amplitudes were summed over 1-minute periods to yield an estimate of MSNA in 39 .3±0.9 mm Hg (P<.001). The increase in minute ventilation was due to an increase in tidal volume, as there was no significant change in the respiratory rate, 15±1.4 versus 14.7±2.2/min. Most subjects experienced mild to moderate chest discomfort, anxiety, dyspnea, flushing, and heart pounding during dipyridamole infusion, all of which completely resolved within 5 minutes after completing the dipyridamole infusion.
The effects of dipyridamole on sympathetic activity and ventilation had different time courses (Fig 3) . Sympathetic nerve activity increased immediately during the infusion of dipyridamole and remained at approximately 80% of the maximal effect for at least 25 minutes. The changes in heart rate paralleled the changes in MSNA during the 25 minutes after dipyridamole infusion. Systolic blood pressure increased gradually over 10 minutes after the infusion was begun and returned to baseline over the following 20 There was an initial increase in ventilation by approximately 50% at the end of the infusion of dipyridamole, which lasted for less than 3 minutes and was followed by a rapid return toward baseline (Fig 3) . The increase in minute ventilation at 5, 10, and 20 minutes after dipyridamole infusion was 20%, 10%, and 5%, respectively. The time course of changes in end-tidal CO2 reflected the changes in hyperventilation. Dipyridamole During Hyperoxia Breathing 100% oxygen, which increased 02 saturation from 98±0.4% to 100±0.02% (P<.001), had no significant effect on sympathetic nerve activity, blood pressure, heart rate, or central venous pressure. Hyperoxia slightly decreased end-tidal CO2 due to a small increase in minute ventilation (Table) . The 4) . There were no significant differences between changes in MSNA, blood pressure, and heart rate in response to dipyridamole during hyperoxia compared with those observed in response to dipyridamole during room air breathing.
Dipyridamole After Pretreatment With Aminophylline
Aminophylline antagonized the effects of dipyridamole (n=7) during room air breathing (Fig 5) . After pretreatment with aminophylline (mean plasma level, 14±1 ,g/mL), dipyridamole increased MSNA by only 27±4%, the number of sympathetic bursts per minute by 17±5%, and heart rate by 11±1%. These 
Discussion
The novel findings of this study are first, that endogenous adenosine increases sympathetic nerve activity and ventilation in conscious subjects and second, that chemoreflex suppression by hyperoxia differentially inhibits ventilatory but not sympathetic or hemodynamic responses to endogenous adenosine. Thus, the sympathoexcitatory effects of endogenous adenosine may be mediated by additional afferent mechanisms independent of peripheral chemoreceptors.
The stimulatory effect of adenosine on ventilation, as reflected by a decrease in end-tidal C02, was related to an increase in tidal volume rather than an increase in respiratory rate or hypoxia. We observed a 20% increase in ventilation, similar to that reported by Maxwell et al (in response to 80 gg/kg per minute of adenosine)3233 but less than the 100% increase observed by Biaggioni et al19 for the same dose of adenosine. The difference in magnitude of ventilatory stimulation in response to adenosine between our study and that of Biaggioni et al is probably related to the time of measurement. The maximal excitatory effect of adenosine on ventilation in our study was transient, lasting <3 minutes in each subject, as opposed to the more sustained cardiovascular and sympathoexcitatory effects. We averaged all measurements during a 3-minute steady-state period after administration of dipyridamole, whereas in the study by Biaggioni et al, the increase in minute ventilation was analyzed over a 1-minute period during which a maximal effect was noted,19 usually during or right after administration of adenosine. However, after infusion of 0.4 mg/kg of dipyridamole, plasma adenosine levels have been shown to increase steadily during dipyridamole infusion to approximately 90% of the peak value at the end of infusion and to remain above 90% of the peak value for at least 1 hour after the end of dipyridamole infusion. 24 To demonstrate that the ventilatory and cardiovascular actions of dipyridamole were mediated by its effects on endogenous adenosine (nucleoside transport inhibition), the effects of dipyridamole were evaluated after pretreatment with aminophylline, a nonselective competitive Al-and A2-adenosine receptor antagonist.34
Aminophylline either abolished the effects of dipyridamole (blood pressure, central venous pressure, minute ventilation, and end-tidal C02) or significantly attenuated its effects (sympathetic nerve activity and heart rate), thereby confirming that these effects of dipyridamole are mediated at the adenosine receptor level. Although methylxanthines may also inhibit phosphodiesterase35 and induce calcium release from the endoplasmic reticulum,36 the concentrations required to achieve these effects are generally 10 times higher than those achieved in this study. However, partial inhibition of phosphodiesterase by aminophylline may explain in part the baseline changes induced by aminophylline alone, for example, a small but significant increase in sympathetic nerve activity and blood pressure. Nevertheless, aminophylline antagonized (rather than potentiated) the cardiovascular and ventilatory effects of dipyridamole, indicating that its predominant effects A. were related to its antagonism of adenosine rather than to its effects on phosphodiesterase inhibition. The sympathoexcitatory effects of dipyridamole could in theory also be attributed to the inhibitory effect of dipyridamole on cAMP phosphodiesterase rather than to potentiation of the effects of endogenous adenosine.37 That phosphodiesterase inhibition did not play a major role in our study is evident from the fact that the effects of dipyridamole could be almost completely abolished by aminophylline, which is also a phosphodiesterase inhibitor.35 It is also possible that activation of sympathetic nerve activity in response to dipyridamole was a nonspecific effect due to chest discomfort experienced by some of the subjects after administration of dipyridamole. This, however, is unlikely because an increase in sympathetic nerve activity was also present in subjects who did not experience chest discomfort during dipyridamole infusion, elevated sympathetic activity persisted much longer (>20 minutes) than the duration of symptoms (<5 minutes), and chest discomfort mimicking anginal pain has been shown to be a specific effect of adenosine thought to be mediated by stimulation of cardiac afferents.38 Although we did not measure plasma levels of adenosine after dipyridamole administration, the dose of dipyridamole used in this study is the same as that used in thallium imaging studies and previously has been shown to approximately double coronary sinus39 and plasma adenosine levels.24 Our results are therefore consistent with the hypothesis that the sympathoexcitatory effects of dipyridamole are due to augmentation of endogenous adenosine activity within a physiological range.
The mechanism(s) by which adenosine stimulates sympathetic activity and ventilation are not completely understood. One possibility is that the decrease in central venous pressure or systemic vascular resistance in response to dipyridamole is solely responsible for the increase in sympathetic nerve activity (by a baroreceptor reflex). Although mean systolic pressure increased, it is possible that even the small decrease in central venous pressure observed in our study contributed to sympathetic activation by unloading of low-pressure cardiopulmonary baroreceptors. In a previous study conducted in a similar group of volunteers, we showed that sympathetic nerve activity increases 27% in response to a decrease in central venous pressure of 1 mm Hg. 40 Therefore, the increase in sympathetic nerve activity in this study (108%) cannot be solely accounted for by a fall in central venous pressure. In addition, the increased sympathetic nerve activity occurs despite a higher mean arterial pressure, increased minute ventilation, and hypocapnia, all of which would be expected to inhibit MSNA.41,42 Thus, endogenous adenosine is a potent mechanism for increasing MSNA. Direct central actions of adenosine are also unlikely to have contributed to the observed effects of dipyridamole, because dipyridamole is not known to cross the blood-brain barrier (personal communication, DuPont Pharmaceutical Co). Any endogenous adenosine that crosses the blood-brain barrier would elicit a depressive, not a stimulatory effect. 12.13 It has been suggested that the effects of adenosine on sympathetic activation and ventilation are related to Engelstein et al Dipyridamole and Sympathetic Activity 2925 activation of chemoreceptors in the carotid sinus. This is based on two lines of evidence: First, Monteiro and Ribeiro21 have shown in anesthetized rats that intracarotid injection of adenosine and especially specific A2-adenosine receptor analogues stimulate ventilation and that these excitatory effects are abolished after sectioning the carotid sinus nerve. Second, it has been observed that infusion of exogenous adenosine, which has a half-life of <1.5 seconds,43 increases ventilation and systolic blood pressure when infused proximal to the origin of carotid arteries (and carotid chemoreceptors) but has minimal effect when infused in the descending aorta.9, 44 Based on the above data, we originally hypothesized that the sympathoexcitatory actions of endogenous adenosine in humans would also be mediated by peripheral chemoreceptors. Therefore, it was expected that suppression of peripheral chemoreceptors during inhalation of 100% oxygen (hyperoxia) would attenuate or abolish the observed sympathoexcitatory and ventilatory effects of dipyridamole. Chemoreceptor discharge has been shown to be almost completely absent above a Pao, of 190±40 mm Hg (range, 140 to 400 mm Hg). 45 Under the conditions present in this study, an increase in Fio, from 21% to 100% is expected to increase Pao, to at least 400 mm Hg."6 The fact that ventilation did not change in response to hyperoxia in our study is a physiological response to 100% oxygen breathing rather than evidence against inhibition of chemoreceptor activity by hyperoxia. A decrease in ventilation reflecting the pure effect of hyperoxia on peripheral chemoreceptors can only be observed during the first few breaths after initiation of oxygen breathing ("single-breath 02 test").31 After that, minute ventilation reflects the net effect of respiratory inhibition resulting from the effect of hyperoxia on peripheral chemoreceptors and the excitatory effect of hyperoxia on central chemoreceptors. 47 In the present study, the effects of dipyridamole on minute ventilation were averaged during successive 60-second intervals. Therefore, the initial transient decrease in ventilation due to hyperoxia would not have been reflected by our method of measurement.
Suppression of peripheral chemoreceptors in this study with hyperoxia attenuated the ventilatory stimulation by dipyridamole, but the sympathetic excitation and the increase in heart rate and blood pressure were preserved (Fig 5) . This suggests that endogenous adenosine affects ventilation predominantly via activation of peripheral chemoreceptors but that the sympathoexcitatory and cardiovascular changes are mediated by activation of additional afferent inputs. This is also supported by the different time course for the effect of adenosine on ventilation and cardiovascular changes (Fig 4) , since the latter were sustained over at least 20 minutes, whereas the increase in ventilation lasted <5 minutes. Our findings that adenosine's effect on ventilation can be modified by suppression of peripheral chemoreceptors are consistent with the experimental data reported by Monteiro and Ribeiro.21 Although the sympathoexcitatory effects of exogenous adenosine infusion into the proximal aortic arch are suggestive of an action by carotid body chemoreceptors, this does not exclude the possibility that increased levels of endogenous adenosine also activate other afferent inputs to the sympathetic nervous system. Several afferent inputs to the autonomic nervous system, in addition to the carotid chemoreceptors, have been shown to be activated by adenosine and may potentially contribute to its sympathoexcitatory effects.
A reflex increase in blood pressure after intracoronary administration of adenosine (in concentrations that have no direct systemic effect) suggest that cardiac afferents are sensitive to adenosine and result in reflex sympathetic activation.48 Furthermore, adenosine and dipyridamole have been shown to increase renal sympathetic nerve activity by activation of cardiac sympathetic afferents mediated by the adenosine A1-receptor. 49 In addition, infusion of adenosine into the renal artery as well as renal pelvic administration of adenosine in dogs with intact renal nerves are associated with increased activity of the sympathetic nervous system and an increase in blood pressure, providing evidence for adenosine-sensitive nerve endings located within or near the renal pelvis. 50 We cannot exclude the possibility that suppression of chemoreceptors by hyperoxia does not alter the ability of chemoreceptors to respond to stimulation by endogenous adenosine. The fact that hyperoxia altered the ventilatory response to dipyridamole indicates, however, that there is an interaction between the adenosine receptors and hyperoxia at the chemoreceptor level. Furthermore, hyperoxia has previously been shown to suppress the ability of chemoreceptors to respond to stimulation by catecholamines.51 A more likely explanation is the possibility of redundancy in the effects of adenosine on sympathetic activity and hemodynamics, namely that adenosine elicits sympathetic activation by stimulation of several different afferents, the net effect of which is less than additive. Attenuation of one of these afferent inputs (in this case, suppression of chemoreceptor afferents by hyperoxia) does not eliminate the sympathetic response because of persistence of activation of other afferents.
Summary
We have shown that endogenous adenosine elicits increases in minute ventilation, sympathetic nerve activity, heart rate, and blood pressure in normal humans. Suppression of peripheral chemoreceptors by hyperoxia attenuates the ventilatory but not the sympathetic or hemodynamic responses to endogenous adenosine. We speculate that activation of afferents other than the peripheral chemoreceptors contribute to the sympathetic and hemodynamic responses to adenosine. These afferents may interact with the chemoreceptors in a redundant fashion.
